NewAC-SH-107
GLP-1 + Cagrilintide
Weight Loss & MetabolicPurity: 99%
Dual compound research blend combining GLP-1 (Semaglutide) and Cagrilintide for synergistic incretin + amylin pathway research in metabolic models.
1
Dual compound research blend combining GLP-1 (Semaglutide) and Cagrilintide for synergistic incretin + amylin pathway research in metabolic models.
Related Compounds
PremiumAC-WL-101
GLP-1
Studied in metabolic and endocrinology research for its interaction with incretin and energy-balance pathways in cell and animal models.
From $38.00
Best SellerAC-WL-102
GLP-2
Dual GIP/GLP-1 receptor agonist studied extensively in metabolic research for energy regulation and body composition pathways.
From $43.00
NewAC-WL-103
GLP-3
Triple GIP/GLP-1/Glucagon receptor agonist investigated in advanced metabolic research models for its multi-receptor activity.
From $62.00
AC-WL-104
MOTS-c
Mitochondrial-derived peptide studied for its role in metabolic regulation, insulin sensitivity pathways, and cellular energy homeostasis.
From $30.00